Abstract
Two prophylactic measures are available in the control of tuberculosis and each has its place, depending on the epidemiologic situation. Immunization, or BCG vaccination, must be considered for the uninfected when there is a high risk of becoming infected. Preventive therapy, or chemoprophylaxis, is directed at those already infected, especially in situations in which the risk of infection is slight or where the risk of disease, given infection, is high.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hart PD’A, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council. Br Med J 1977;2:293–295.
Comstock GW, Livesay VT, Woolpert SF: Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 1974;64:283–291.
Comstock GW, Woolpert SF, Livesay VT: Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep 1976;91:276–280.
Tripathy SP: Fifteen-year follow-up of the Indian BCG prevention trial. Bull Int Union Tuberc 1987;62:69–72.
International Union against Tuberculosis: Phenotypes of BCG-vaccines seed lot strains: Results of an international cooperative study. Tubercle 1978;59:139–142.
Comstock GW: Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988;138:479–480.
Wiegeshaus EH, Harding G, McMurray D, et al: A cooperative evaluation of test systems used to assay tuberculosis vaccines. Bull WHO 1971;45:543–550.
Smith PG: Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method. Tubercle 1982; 63:23–35.
Comstock GW: Vaccine evaluation by case-control or prospective studies. Am J Epidemiol 1990;131:205–207.
Raj Narain, Vallishayee RS: BCG vaccination of tuberculous patients and of strong reactors to tuberculin. Bull Int Union Tuberc 1976;51:243–246.
Rouillon A, Waaler H: BCG vaccination and epidemiological situation. A decision making approach to the use of BCG. Adv Tuberc Res 1976;19:64–126.
Springett VH: The value of BCG vaccination. Tubercle 1965;46:76–84.
Centers for Disease Control, Tuberculosis Control Division: Tuberculosis among Indochinese refugees—United States, 1979. MMWR 1980;29:383–390.
Centers for Disease Control: Use of BCG vaccines in the control of tuberculosis: A joint statement by the ACIP and the Advisory Committee for Elimination of Tuberculosis. MMWR 1988;37:663–675.
Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis. A general review. Adv Tuberc Res 1970;17:28–106.
Comstock GW, Woolpert SF: Preventive therapy, in Kubica GP, Wayne LG (eds): The Mycobacteria. A Sourcebook. New York, Marcel Dekker, 1984, pp. 1971–1982.
Comstock GW, Baum C, Snider DE Jr.: Iso-niazid prophylaxis among Alaskan Eskimos: A final report of the Bethel isoniazid studies. Am Rev Respir Dis 1979;119:827–830.
Falk A, Fuchs GF: Prophylaxis with isoniazid in inactive tuberculosis. Chest 1978;73:44–48.
Comstock GW, Hammes LM, Pio A: Isoniazid prophylaxis in Alaskan boarding schools. A comparison of two doses. Am Rev Respir Dis 1969;100:773–779.
Horwitz O, Magnus K: Epidemiologic evaluation of chemoprophylaxis against tuberculosis. Twelve year follow-up of a community-wide controlled trial with special reference to the sampling methods. Am J Epidemiol 1974; 99:333–342.
Comstock GW, Ferebee SH: How much isoniazid is needed for prophylaxis? Am Rev Respir Dis 1970;101:780–782.
Kopanoff DE, Snider DE Jr, Caras GJ: Isoniazid-related hepatitis. A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991–1001.
Rose DN, Schnechter CB, Silver AL: The age threshold for isoniazid chemoprophylaxis: a decision analysis for low-risk tuberculin reactors. JAMA 1986;256:2709–2713.
American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986;134:355–363.
Dash LA, Comstock GW, Flynn JPG: Isoniazid preventive therapy: Retrospect and prospect. Am Rev Respir Dis 1980;121:1039–1044.
Iseman MD: Containment of tuberculosis: Preventive therapy with isoniazid and contact investigation. Chest 1979;76(suppl):801–804.
Stead WW: Control of tuberculosis in institutions. Chest 1979;76(suppl):797–800.
Centers for Disease Control: The use of preventive therapy for tuberculous infection in the United States. MMWR 1990;39:(No. RR-8)9–12.
American Thoracic Society: Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725–735.
Villarino ME, Dooley SW Jr, Geiter LJ, Castro KG, Snider DE Jr: Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992;41:No.RR-11, 59–71.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Comstock, G.W., Geiter, L.J. (1994). Prophylaxis. In: Schlossberg, D. (eds) Tuberculosis. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8321-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-8321-5_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-8323-9
Online ISBN: 978-1-4613-8321-5
eBook Packages: Springer Book Archive